10-K Filing

ZIMMER BIOMET HOLDINGS, INC. CIK: 1136869 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001564590-20-005657`
Period End Date	20191231
Filing Date	20200221
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	zbh-10k_20191231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 98 Cash Flow Statement 103 Stockholders Equity 25 Comprehensive Income 27

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$617.90M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	309.90M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	307.90M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$542.80M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts	`AccountsReceivableNetCurrent`	$1.28B	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	103.90M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts	`AccountsReceivableNetCurrent`	$1.36B	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	103.90M	shares	Point-in-time
Inventories	`InventoryNet`	$2.38B	USD	Point-in-time
Inventories	`InventoryNet`	$2.26B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$352.30M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$357.10M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$4.43B	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$4.72B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$2.02B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$2.08B	USD	Point-in-time
Goodwill	`Goodwill`	$10.67B	USD	Point-in-time
Goodwill	`Goodwill`	$9.60B	USD	Point-in-time
Goodwill	`Goodwill`	$9.59B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.26B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.68B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$980.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$405.00M	USD	Point-in-time
Total Assets	`Assets`	$24.64B	USD	Point-in-time
Total Assets	`Assets`	$24.13B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$362.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$400.90M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$142.40M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$126.70M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.39B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.41B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$525.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.50B	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.44B	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.42B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$840.10M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$999.50M	USD	Point-in-time
Long-term income tax payable	`AccruedIncomeTaxesNoncurrent`	$666.20M	USD	Point-in-time
Long-term income tax payable	`AccruedIncomeTaxesNoncurrent`	$685.10M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$557.80M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$350.00M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$8.41B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$6.72B	USD	Point-in-time
Total Liabilities	`Liabilities`	$12.25B	USD	Point-in-time
Total Liabilities	`Liabilities`	$12.85B	USD	Point-in-time
Commitments and Contingencies (Note 20)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 20)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, one billion shares authorized, 309.9 million (307.9 million in 2018) issued	`CommonStockValue`	$3.10M	USD	Point-in-time
Common stock, $0.01 par value, one billion shares authorized, 309.9 million (307.9 million in 2018) issued	`CommonStockValue`	$3.10M	USD	Point-in-time
Paid-in capital	`AdditionalPaidInCapitalCommonStock`	$8.69B	USD	Point-in-time
Paid-in capital	`AdditionalPaidInCapitalCommonStock`	$8.92B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$9.49B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$10.43B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-187.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-241.90M	USD	Point-in-time
Treasury stock, 103.9 million shares (103.9 million shares in 2018)	`TreasuryStockValue`	$6.72B	USD	Point-in-time
Treasury stock, 103.9 million shares (103.9 million shares in 2018)	`TreasuryStockValue`	$6.72B	USD	Point-in-time
Total Zimmer Biomet Holdings, Inc. stockholders' equity	`StockholdersEquity`	$12.39B	USD	Point-in-time
Total Zimmer Biomet Holdings, Inc. stockholders' equity	`StockholdersEquity`	$11.27B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.80M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.70M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.67B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.39B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.28B	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$24.13B	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$24.64B	USD	Point-in-time

Income Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.89B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.84B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.02B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.98B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.98B	USD	Annual
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.07B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.99B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.01B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.93B	USD	Annual
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.13B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.80B	USD	Annual
Cost of products sold, excluding intangible asset amortization	`CostOfGoodsAndServicesSold`	$2.27B	USD	Annual
Cost of products sold, excluding intangible asset amortization	`CostOfGoodsAndServicesSold`	$2.25B	USD	Annual
Cost of products sold, excluding intangible asset amortization	`CostOfGoodsAndServicesSold`	$2.13B	USD	Annual
Intangible asset amortization	`AmortizationOfIntangibleAssets`	$603.90M	USD	Annual
Intangible asset amortization	`AmortizationOfIntangibleAssets`	$595.90M	USD	Annual
Intangible asset amortization	`AmortizationOfIntangibleAssets`	$584.30M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$369.90M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$391.70M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$449.30M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.38B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.10B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.34B	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$70.10M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$331.50M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$979.70M	USD	Annual
Quality remediation	`QualityRemediationCosts`	$146.90M	USD	Annual
Quality remediation	`QualityRemediationCosts`	$82.40M	USD	Annual
Quality remediation	`QualityRemediationCosts`	$181.30M	USD	Annual
Restructuring and other cost reduction initiatives	`RestructuringAndOtherCostReductionInitiatives`	$17.60M	USD	Annual
Restructuring and other cost reduction initiatives	`RestructuringAndOtherCostReductionInitiatives`	$34.20M	USD	Annual
Restructuring and other cost reduction initiatives	`RestructuringAndOtherCostReductionInitiatives`	$50.00M	USD	Annual
Acquisition, integration and related	`AcquisitionIntegrationAndRelatedExpenses`	$262.20M	USD	Annual
Acquisition, integration and related	`AcquisitionIntegrationAndRelatedExpenses`	$99.50M	USD	Annual
Acquisition, integration and related	`AcquisitionIntegrationAndRelatedExpenses`	$12.20M	USD	Annual
Operating expenses	`CostsAndExpenses`	$6.84B	USD	Annual
Operating expenses	`CostsAndExpenses`	$7.90B	USD	Annual
Operating expenses	`CostsAndExpenses`	$7.00B	USD	Annual
Operating Profit	`OperatingIncomeLoss`	$1.14B	USD	Annual
Operating Profit	`OperatingIncomeLoss`	$33.80M	USD	Annual
Operating Profit	`OperatingIncomeLoss`	$799.30M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-4.80M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-9.40M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-15.60M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-226.90M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-325.30M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-289.30M	USD	Annual
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-271.10M	USD	Annual
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$905.80M	USD	Annual
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$464.60M	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-1.35B	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$108.20M	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-225.70M	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$1.81B	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$-379.30M	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$1.13B	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-400.00K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$431.10M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$-379.20M	USD	Annual
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$320.70M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$1.13B	USD	Annual
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$246.10M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$1.81B	USD	Annual
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$174.70M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$-901.10M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$133.70M	USD	1 Quarter
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$162.20M	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$0.65	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$-4.42	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$8.98	USD	Annual
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$0.80	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$-1.86	USD	Annual
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$0.86	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$1.56	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$5.52	USD	Annual
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$1.20	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$2.10	USD	1 Quarter
Earnings (Loss) Per Common Share - Basic	`EarningsPerShareBasic`	$0.91	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$8.90	USD	Annual
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$2.08	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$1.54	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$0.79	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$0.85	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$5.47	USD	Annual
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$-4.42	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$0.65	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$0.90	USD	1 Quarter
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$-1.86	USD	Annual
Earnings (Loss) Per Common Share - Diluted	`EarningsPerShareDiluted`	$1.20	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	205.10M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	201.90M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	203.50M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	203.70M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	206.70M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	203.50M	shares	Annual

Cash Flow Statement 103 line items

Line Item	Tag	Value	Unit	Period
Net Earnings (Loss)	`ProfitLoss`	$1.81B	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$-379.30M	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$1.13B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.01B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.06B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.04B	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$65.50M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$84.30M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$53.70M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$70.10M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$331.50M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$979.70M	USD	Annual
Inventory step-up	`InventoryStepUp`	$32.80M	USD	Annual
Deferred income tax benefit (provision)	`DeferredIncomeTaxExpenseBenefit`	$-538.70M	USD	Annual
Deferred income tax benefit (provision)	`DeferredIncomeTaxExpenseBenefit`	$-1.78B	USD	Annual
Deferred income tax benefit (provision)	`DeferredIncomeTaxExpenseBenefit`	$13.40M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$111.40M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$150.20M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-150.80M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$93.80M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$-161.70M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$-213.60M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$199.50M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$120.10M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$125.20M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-42.00M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-133.30M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$155.90M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-8.40M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-5.70M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$17.90M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.59B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.75B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.58B	USD	Annual
Additions to instruments	`AdditionsToInstruments`	$337.00M	USD	Annual
Additions to instruments	`AdditionsToInstruments`	$315.90M	USD	Annual
Additions to instruments	`AdditionsToInstruments`	$276.30M	USD	Annual
Additions to other property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$162.70M	USD	Annual
Additions to other property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$156.00M	USD	Annual
Additions to other property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$207.10M	USD	Annual
Net investment hedge settlements	`ProceedsFromHedgeInvestingActivities`	$69.20M	USD	Annual
Net investment hedge settlements	`ProceedsFromHedgeInvestingActivities`	$48.10M	USD	Annual
Business combination investments, net of acquired cash	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$37.10M	USD	Annual
Business combination investments, net of acquired cash	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$15.30M	USD	Annual
Business combination investments, net of acquired cash	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$4.00M	USD	Annual
Investments in other assets	`PaymentsForProceedsFromOtherInvestingActivities`	$13.80M	USD	Annual
Investments in other assets	`PaymentsForProceedsFromOtherInvestingActivities`	$19.70M	USD	Annual
Investments in other assets	`PaymentsForProceedsFromOtherInvestingActivities`	$31.50M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-416.60M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-729.30M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-510.80M	USD	Annual
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$549.20M	USD	Annual
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$749.50M	USD	Point-in-time
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$549.20M	USD	Point-in-time
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$749.50M	USD	Annual
Proceeds from multicurrency revolving facility	`ProceedsFromLinesOfCredit`	$400.00M	USD	Annual
Proceeds from multicurrency revolving facility	`ProceedsFromLinesOfCredit`	$400.00M	USD	Annual
Payments on multicurrency revolving facility	`RepaymentsOfLinesOfCredit`	$400.00M	USD	Annual
Payments on multicurrency revolving facility	`RepaymentsOfLinesOfCredit`	$400.00M	USD	Annual
Redemption of senior notes	`MaturitiesOfSeniorDebt`	$500.00M	USD	Annual
Redemption of senior notes	`MaturitiesOfSeniorDebt`	$500.00M	USD	Annual
Redemption of senior notes	`MaturitiesOfSeniorDebt`	$1.15B	USD	Annual
Proceeds from term loans	`ProceedsFromIssuanceOfUnsecuredDebt`	$192.70M	USD	Annual
Proceeds from term loans	`ProceedsFromIssuanceOfUnsecuredDebt`	$200.00M	USD	Annual
Proceeds from term loans	`ProceedsFromIssuanceOfUnsecuredDebt`	$675.00M	USD	Annual
Payments on term loans	`RepaymentsOfUnsecuredDebt`	$960.00M	USD	Annual
Payments on term loans	`RepaymentsOfUnsecuredDebt`	$940.00M	USD	Annual
Payments on term loans	`RepaymentsOfUnsecuredDebt`	$1.43B	USD	Annual
Net payments on other debt	`ProceedsFromRepaymentsOfOtherDebt`	$-900.00K	USD	Annual
Net payments on other debt	`ProceedsFromRepaymentsOfOtherDebt`	$-5.30M	USD	Annual
Net payments on other debt	`ProceedsFromRepaymentsOfOtherDebt`	$-3.90M	USD	Annual
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$196.70M	USD	Annual
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$193.60M	USD	Annual
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$195.20M	USD	Annual
Proceeds from employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$145.50M	USD	Annual
Proceeds from employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$158.20M	USD	Annual
Proceeds from employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$107.90M	USD	Annual
Net cash flows from unremitted collections from factoring programs	`NetCashFlowsBetweenTransfereeAndTransferorUnremittedCollectionsFromFactoringPrograms`	$12.20M	USD	Annual
Net cash flows from unremitted collections from factoring programs	`NetCashFlowsBetweenTransfereeAndTransferorUnremittedCollectionsFromFactoringPrograms`	$-103.50M	USD	Annual
Net cash flows from unremitted collections from factoring programs	`NetCashFlowsBetweenTransfereeAndTransferorUnremittedCollectionsFromFactoringPrograms`	$36.70M	USD	Annual
Business combination contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.90M	USD	Annual
Business combination contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$19.80M	USD	Annual
Business combination contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$9.10M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-8.60M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.20M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-4.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.21B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.30B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-779.90M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.30M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-10.20M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-1.50M	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$18.40M	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-109.70M	USD	Annual
Increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$75.10M	USD	Annual
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$542.80M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$634.10M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$524.40M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$617.90M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$542.80M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$634.10M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$524.40M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$617.90M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Cash dividend declared per share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	Annual
Cash dividend declared per share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	Annual
Cash dividend declared per share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.67B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.39B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.28B	USD	Point-in-time
Net (loss) earnings	`ProfitLoss`	$1.81B	USD	Annual
Net (loss) earnings	`ProfitLoss`	$-379.30M	USD	Annual
Net (loss) earnings	`ProfitLoss`	$1.13B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-61.30M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-54.50M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$349.90M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$197.20M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$195.50M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$194.10M	USD	Annual
Retrospective adoption of new accounting standard	`NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification`	$-77.80M	USD	Annual
Sale of shares in a subsidiary without loss of control	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$5.20M	USD	Annual
Stock compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$174.20M	USD	Annual
Stock compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$236.90M	USD	Annual
Stock compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$171.50M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.67B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.39B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.28B	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net Earnings (Loss)	`ProfitLoss`	$1.81B	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$-379.30M	USD	Annual
Net Earnings (Loss)	`ProfitLoss`	$1.13B	USD	Annual
Foreign currency cumulative translation adjustments, net of tax	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-135.40M	USD	Annual
Foreign currency cumulative translation adjustments, net of tax	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.50M	USD	Annual
Foreign currency cumulative translation adjustments, net of tax	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$445.00M	USD	Annual
Unrealized cash flow hedge gains/(losses), net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$30.60M	USD	Annual
Unrealized cash flow hedge gains/(losses), net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$68.20M	USD	Annual
Unrealized cash flow hedge gains/(losses), net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$-95.00M	USD	Annual
Reclassification adjustments on cash flow hedges, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$35.10M	USD	Annual
Reclassification adjustments on cash flow hedges, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$3.80M	USD	Annual
Reclassification adjustments on cash flow hedges, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$-23.60M	USD	Annual
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$48.50M	USD	Annual
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-4.60M	USD	Annual
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$17.70M	USD	Annual
Total Other Comprehensive (Loss) Income	`OtherComprehensiveIncomeLossNetOfTax`	$-61.30M	USD	Annual
Total Other Comprehensive (Loss) Income	`OtherComprehensiveIncomeLossNetOfTax`	$-54.50M	USD	Annual
Total Other Comprehensive (Loss) Income	`OtherComprehensiveIncomeLossNetOfTax`	$350.80M	USD	Annual
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Annual
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-440.60M	USD	Annual
Comprehensive Income (Loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.16B	USD	Annual
Comprehensive Loss Attributable to Noncontrolling Interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.30M	USD	Annual
Comprehensive Loss Attributable to Noncontrolling Interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Comprehensive Loss Attributable to Noncontrolling Interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Comprehensive Income (Loss) Attributable to Zimmer Biomet Holdings, Inc.	`ComprehensiveIncomeNetOfTax`	$1.08B	USD	Annual
Comprehensive Income (Loss) Attributable to Zimmer Biomet Holdings, Inc.	`ComprehensiveIncomeNetOfTax`	$2.17B	USD	Annual
Comprehensive Income (Loss) Attributable to Zimmer Biomet Holdings, Inc.	`ComprehensiveIncomeNetOfTax`	$-440.50M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.